Get started
Author

Carolina Tiraboschi

Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials
2020 · Daniel Compagno, Carolina Tiraboschi, et al. · Biomolecules · 60
PDF
Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer
2017 · Lucas Daniel Gentilini, Felipe Martín Jaworski, et al. · Oncotarget · 46
PDF
Polyfunctional KLRG-1+CD57+ Senescent CD4+ T Cells Infiltrate Tumors and Are Expanded in Peripheral Blood From Breast Cancer Patients
2021 · Maria C. Ramello, Nicolás G. Núñez, et al. · Frontiers in Immunology · 43
PDF
Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome
2020 · Carolina Tiraboschi, Lucas Gentilini, et al. · Journal for ImmunoTherapy of Cancer · 23
PDF
Galectin-3 as a new negative checkpoint of the immune response is the key target for effective immunotherapy against prostate cancer
2019 · Carolina Tiraboschi, Lucas Gentilini, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 5
PDF
Abstract 400: Functional, structural and binding studies of the atypical ER-resident protein FKBP7, a potential target in chemoresistant prostate cancer
2022 · Luce Dreno, Carolina Tiraboschi, et al. · Cancer Research · 2
Cytoplasmic FKBP7 reflux sustains NFE2L1 levels in an adaptive response to chemotherapy in prostate cancer cells
2026 · Luce Dreno, Farès Ousalem, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Functional, Structural and Binding Studies of the Atypical Er-resident Protein Fkbp7, a Potential Target in Chemoresistant Prostate Cancer
2021 · Dreno, Luce, Lacoste, Sofian, et al. · HAL (Le Centre pour la Communication Scientifique Directe)
Abstract 3960: Low doses of Docetaxel in combination with anti-prostate cancer immunotherapy lead to complete tumor-free outcome through Galectin-3 silencing
2019 · Daniel Compagno, Carolina Tiraboschi, et al. · Immunology
Abstract 3960: Low doses of Docetaxel in combination with anti-prostate cancer immunotherapy lead to complete tumor-free outcome through Galectin-3 silencing
2019 · Daniel Compagno, Carolina Tiraboschi, et al. · Cancer Research
Works count: 10
Citation count: 179
H-index: 5
I10-index: 4
Year
Topic
Type